Mohammad Saidal LaVanway Mohmand, the Chief Financial Officer of $APLD, sold 37,503 shares of the company on 10-28-2025 for an estimated $1,367,734. We received data on the trade from a recent SEC filing. This was a sale of approximately 23.6% of their shares of this class of stock. Following this trade, they now own 121,409 shares of this class of $APLD stock.
$APLD Insider Trading Activity
$APLD insiders have traded $APLD stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $APLD stock by insiders over the last 6 months:
- WES CUMMINS (CEO; Chairman) sold 400,000 shares for an estimated $6,104,000
- MOHAMMAD SAIDAL LAVANWAY MOHMAND (Chief Financial Officer) has made 0 purchases and 3 sales selling 212,503 shares for an estimated $5,920,234.
- RICHARD N NOTTENBURG has made 0 purchases and 4 sales selling 79,311 shares for an estimated $1,778,531.
- CHUCK HASTINGS has made 0 purchases and 2 sales selling 130,000 shares for an estimated $1,774,900.
- RACHEL H. LEE has made 0 purchases and 2 sales selling 48,425 shares for an estimated $973,355.
- DOUGLAS S MILLER has made 0 purchases and 2 sales selling 20,000 shares for an estimated $286,300.
- ELLA G. BENSON sold 18,242 shares for an estimated $118,573
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$APLD Hedge Fund Activity
We have seen 183 institutional investors add shares of $APLD stock to their portfolio, and 132 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OASIS MANAGEMENT CO LTD. removed 7,700,000 shares (-88.2%) from their portfolio in Q2 2025, for an estimated $77,539,000
- BNP PARIBAS FINANCIAL MARKETS added 5,198,223 shares (+24356.8%) to their portfolio in Q2 2025, for an estimated $52,346,105
- CLEARFIELD CAPITAL MANAGEMENT LP removed 3,607,000 shares (-86.4%) from their portfolio in Q2 2025, for an estimated $36,322,490
- D. E. SHAW & CO., INC. removed 3,381,851 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $34,055,239
- VOLORIDGE INVESTMENT MANAGEMENT, LLC added 3,266,164 shares (+inf%) to their portfolio in Q2 2025, for an estimated $32,890,271
- SITUATIONAL AWARENESS LP added 2,556,200 shares (+63.3%) to their portfolio in Q2 2025, for an estimated $25,740,934
- PERTENTO PARTNERS LLP removed 2,235,113 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $22,507,587
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$APLD Analyst Ratings
Wall Street analysts have issued reports on $APLD in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Craig-Hallum issued a "Buy" rating on 10/23/2025
- Lake Street issued a "Buy" rating on 10/10/2025
- Northland Capital Markets issued a "Outperform" rating on 10/10/2025
- Needham issued a "Buy" rating on 10/10/2025
- HC Wainwright & Co. issued a "Buy" rating on 10/10/2025
- JMP Securities issued a "Market Outperform" rating on 10/09/2025
- Roth Capital issued a "Buy" rating on 10/01/2025
To track analyst ratings and price targets for $APLD, check out Quiver Quantitative's $APLD forecast page.
$APLD Price Targets
Multiple analysts have issued price targets for $APLD recently. We have seen 11 analysts offer price targets for $APLD in the last 6 months, with a median target of $37.0.
Here are some recent targets:
- George Sutton from Craig-Hallum set a target price of $39.0 on 10/23/2025
- Mike Grondahl from Northland Capital Markets set a target price of $40.0 on 10/10/2025
- Rob Brown from Lake Street set a target price of $37.0 on 10/10/2025
- John Todaro from Needham set a target price of $41.0 on 10/10/2025
- Kevin Dede from HC Wainwright & Co. set a target price of $40.0 on 10/10/2025
- Greg Miller from JMP Securities set a target price of $35.0 on 10/09/2025
- Darren Aftahi from Roth Capital set a target price of $43.0 on 10/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
